Author:
Tron Arthur,Schlegel Vincent,Pinot Juliette,BRUEL Sébastien,Ecollan Marie,Bel Josselin Le,Rossignol Louise,Gauchet Aurélie,Gagneux-Brunon Amandine,Mueller Judith,Banaszuk Anne-Sophie,Thilly Nathalie,Gilberg Serge,Partouche Henri
Abstract
Abstract
Background
In France, human papillomavirus (HPV) vaccination coverage is low, with 30.7% of 17-year-old girls having received a complete HPV vaccination schedule in 2020.
Aim
To determine the perspective and behaviors of general practitioners (GPs) regarding HPV vaccination with their patients and if a reluctance is observed.
Design and setting
A qualitative study based on semi-directed individual interviews was conducted between December 2019 and December 2020. A representative sample of GPs with various profiles were included in 4 French regions.
Method
A purposive sampling was used and interviews were continued until data saturation was reached. The analysis was based on the grounded theory.
Results
Twenty-six GPs aged 29–66 years were interviewed. The measures taken by the French health authorities (lowering the target age, reimbursing the vaccine, extending the target population to boys) were perceived as facilitators. The reported barriers were organizational, due to low attendance of adolescents, and relational, mainly due to parental vaccine hesitancy. Physicians had to deal with fears about the perceived risks and concerns about sexuality conveyed by HPV vaccination and linked to the socio-cultural characteristics of the families. Physicians developed strategies, including scientific knowledge mobilization, empowerment of families by promoting health through prevention, repetition of the vaccination proposals, personal experience and relationship. Different practices were identified according to three GP typologies: effective, convinced but unpersuasive, and reluctant physicians.
Conclusion
Based on these results, specific interventions, including communication techniques, especially for hesitant or unpersuasive physicians, are needed to enable GPs to become more effective.
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccines Immunother août. 2013;9(8):1763–73.
2. Larson HJ, de Figueiredo A, Xiahong Z, Schulz WS, Verger P, Johnston IG, et al. The state of Vaccine confidence 2016: global insights through a 67-Country survey. EBioMedicine 13 sept. 2016;12:295–301.
3. Larson HJ, Jarrett C, Eckersberger E, Smith DMD, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine 17 avr. 2014;32(19):2150–9.
4. MacDonald NE, SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope and determinants. Vaccine 14 août. 2015;33(34):4161–4.
5. Bocquier A, Fressard L, Cortaredona S, Zaytseva A, Ward J, Gautier A, et al. Social differentiation of vaccine hesitancy among French parents and the mediating role of trust and commitment to health: a nationwide cross-sectional study. Vaccine. nov 2018;29(50):7666–73.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献